Cerebral vasomotor paralysis during migraine attack.
D000328:Adult; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000097:blood / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004878:Ergotamine / Q000627:therapeutic use; D006801:Humans; D006985:Hyperventilation / Q000503:physiopathology; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy / Q000503:physiopathology*; D010208:Papaverine / Q000627:therapeutic use; D010313:Partial Pressure; D014665:Vasodilator Agents / Q000627:therapeutic use; D014666:Vasomotor System / Q000503:physiopathology*; D014978:Xenon
D014665:Vasodilator Agents; D002245:Carbon Dioxide; D014978:Xenon; D010208:Papaverine; D004878:Ergotamine